Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+440K
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$4.27M
-
Number of buys
-
39
-
Number of sells
-
-49
-
Price
-
$29.64
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2021
115 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2021.
Replimune Group, Inc. - COMMON STOCK (REPL) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 78.4M outstanding shares and own 44.59% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.72M shares), Omega Fund Management, LLC (4.9M shares), Redmile Group, LLC (4.08M shares), BlackRock Inc. (2.09M shares), STATE STREET CORP (1.61M shares), VANGUARD GROUP INC (1.56M shares), Ensign Peak Advisors, Inc (1.29M shares), LOOMIS SAYLES & CO L P (1.14M shares), FMR LLC (1.05M shares), and EMERALD MUTUAL FUND ADVISERS TRUST (1.02M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.